Building a competitiveadvantage for growth

Mayfair Resort, Gangtok

Lower Samdur Block,
Ranipool, Gangtok,
Sikkim 737135

27 September, 2019


Investor-friendly policies with ease of doing business, attractive tax incentives and low cost of manufacturing and labour have made Sikkim favoured destination for pharmaceutical companies. Also, North East Industrial & Investment Promotion Policy (NEIIPP) 2007, gave a further impetus to the state's growth story where pharma companies such as Cipla, Sun Pharma, Zydus Cadila, Alembic, IPCA, Alkem Lab, Intas Pharma, Torrent Pharma and Unichem, were able to set up their base in and around the picturisque Himalayan town.

As Sikkim enters its second decade as pharma hub, the sector needs to identify its challenges and build a more sustainable future beyond tax incentives.


Dr Upendra Quenim

Vice-President Operations, Swiss Garnier

Mr Deepak Verma

General Manager, Zuventus Healthcare

Mr Soumaya Dutt

General Manager & site head, Formulation operations, Glenmark pharmaceuticals, Sikkim

Mr Sasikant Hotta

Unit Head-VP Technical and operation, Micro Labs

Mr Sachin Sangal

Founder & CMD, Xcentric Learning Edge

Mr Amit Sharma

Head-Quality Assurance, Alembic Pharmaceutical

Building a sustainable competitive edge

The second edition of Sikkim Pharma Summit, organised by Express Pharma,

will focus on the theme ‘Building a competitive advantage for growth.' Experts from the pharma and allied industry will discuss and deliberate on how to build a model, which will help the state achieve Government of India's 'Pharma Vision 2030,' and the goal to touch $ 120-130 billion by 2030 from the current $ 38 billion.

A panel discussion on 'In quest of Sikkim's USP', will be held on the sidelines of the summit. Experts and veterans from the pharma industry will discuss Sikkim's journey as a pharma hub in the last few years, the challenges faced and solutions to be implemented.

The panel discussion will analyse on the following topics:

Encourage innovation in formulation and R&D
Scale-up R&D capabilities
Assuring quality of medicines
Enabling regulatory compliance
Develop a cross-functional team culture
Tapping the right talent
Building inclusive employee-friendly policies
Building leadership strategies


DCG( I ), StateDrug Controller and government officials
MDs, CEOs and key decision makers from pharma companies
Technical, Production, Plant/Factory/Unit
QA & QC, R&D, Packaging
Purchase & Procurement
Logistics & supply chain and key influencers from pharma companies


Mayfair Resort, Gangtok

Lower Samdur Block, Ranipool, Gangtok, Sikkim 737135

27 September 2019

The Indian Express Group is one of India’s largest media conglomerates with a wide selection of publications and a network of offices. Today, with 32 national editions, 13 publication centers and 4 language dailies we reach over 19 million people daily.

The Express Group of publications has stood for excellence in journalism for over 80 years. Our Group publications include The Indian Express, The Financial Express, Loksatta, Lokprabha and Jansatta.

Established in 1990, the Business Publications Division (BPD) of the Group manages B2B publications like Express Computer, Express Pharma, Express Healthcare, Express TravelWorld, as well as organises marquee events like Technology Senate, Technology Sabha, Healthcare Senate, Healthcare Sabha, FDD Conclave & BFSI Technology Conclave.

For More Information

Rajesh Bhatkal
Mobile: +91 9821313017, Email:,


Ashish Rampure
Mobile: +91 9664565092,

New Delhi:

Ambuj Kumar
Mobile: +91 9999070900,


Rajesh Bhatkal
Mobile: +91 9821313017,


Usha Sharma
Mobile: +91 8169199462, Email:

Amruta Shinde
Mobile: +91 8080028866, Email:

Muhurta Shinde
Mobile: +91 7303113133, Email:


© The Indian Express (P) Ltd. Event managed by Business Publications Division.